Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 12Small Cell Lung Carcinoma 11Fallopian Tube Neoplasms 9Neuroblastoma 6Neoplasm Metastasis 3Lung Neoplasms 3Ganglioneuroblastoma 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Rhabdoid Tumor 2Recurrence 2Leukemia, Myeloid, Acute 2Glioma 2Central Nervous System Neoplasms 2Wilms Tumor 1Thrombocythemia, Essential 1SCLC 1Primary Myelofibrosis 1Polycythemia Vera 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Vincristine 1Vinblastine 1Topotecan 1Methotrexate 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Choroid Plexus Neoplasms × Topotecan × 90 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡